Document:

Termination Agreement

 Exhibit 10.9 
 Termination of Participation Agreement 
 This Termination Agreement, dated as of December 29,
2008, is between GMAC LLC, a Delaware limited liability company (the “Seller”), General Motors Corporation, a Delaware corporation (“General Motors”), and FIM Holdings LLC, a Delaware limited liability company (“FIM”,
and together with General Motors, each a “Participant” and collectively, the “Participants”). Reference is made to that certain Participation Agreement, dated as of June 4, 2008 (the “Participation Agreement”),
among the Seller, General Motors and Cerberus Rescap Financing LLC (“Cerberus Fund”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Participation Agreement. 
 WITNESSETH: 
 WHEREAS, on or prior to the
date hereof, Cerberus Fund has contributed and assigned its Participation to FIM; 
 WHEREAS, Seller, General Motors, and as a result of such
assignment, FIM are parties to the Participation Agreement; and 
 WHEREAS, Seller, General Motors and FIM now wish to mutually terminate
their rights, title and interests under the Participation Agreement. 
 NOW, THEREFORE, in consideration of the mutual covenants and premises
made herein, the parties hereto agree as follows: 
 1. Effective as of the date hereof, subject to the simultaneous
consummation of the Exchange Agreement, dated the date hereof, by and among Seller, General Motors and FIM, the Participation Agreement is terminated by the mutual agreement of Seller, General Motors and FIM, without further force or effect.

 2. Upon termination of the Participation Agreement, none of Seller, General Motors and FIM shall have any rights,
obligations, or liabilities to the other parties under the Participation Agreement. 
 3. Each party hereto, (in such
capacity, each a “Releasor”) hereby releases and forever discharges the other parties hereto, their respective corporate parents, subsidiaries and affiliates and each of their respective present and former directors, managing directors,
officers, control persons, stockholders, general partners, limited partners, employees, agents, attorneys, administrators, successors, personal representatives, executors and assigns (collectively, the “Released Group”) from any and all
actions, causes of action, injunctions, accounts, agreements, bonds, bills, covenants, contracts, controversies, claims, damages, demands, debts, dues, extents, executions, judgments, liabilities, obligations, promises, predicate acts, reckonings,
specialties, suits, sums of money, and variances whatsoever, whether known or unknown, in law or in equity, which against any of them the Releasor, its corporate parents, subsidiaries and affiliates and each of their present and former directors,
managing directors, officers, control persons, stockholders, general partners, limited partners, 

 
employees, agents, attorneys, administrators, successors, personal representatives, executors and assigns may now have, have ever had, or may hereafter have
against any member of the Released Group arising out of, or in connection with, or in any manner related to, the Participation Agreement (the “Release”); provided, however, that the Releasor does not hereby waive, release or discharge the
Released Group from any of its obligations under this Termination Agreement. 
 4. If GMAC’s separate private exchange
offers and cash tender offers to purchase and/or exchange certain of its and its subsidiaries’ and Residential Capital, LLC’s outstanding notes shall not have been completed at or prior to 11:59 p.m., New York City time, on January 1,
2009 on substantially the terms described in the offering memorandums therefor, each of GM and FIM shall have the right to notify each other party to this Termination Agreement that they wish to rescind this Termination Agreement and upon receipt of
such notification by each such other party hereto prior to 5 p.m., New York City time, on January 5, 2009, this Termination Agreement shall thereupon become null and void, ab initio, as if this Termination Agreement was never executed and the
Participation Agreement was never terminated, and any actions theretofore undertaken pursuant hereto shall immediately thereupon be rescinded and the parties hereto shall be restored to such positions as each occupied immediately prior to the
execution hereof. 
 5. Each Releasor acknowledges that it may hereafter discover claims or facts in addition to or different
from those which it now knows or believes to exist with respect to the subject matter of the Release and which, if known or suspected at the time of executing this Release, may have materially affected this Release. Nevertheless, each Releasor
hereby waives any right, claim, or cause of action that might arise as a result of such different or additional claims or facts. 
 6. This Termination Agreement constitutes the entire agreement and understanding of the parties with respect to the subject matter of this Termination Agreement and supersedes all prior or contemporaneous discussions and agreements, whether
written or oral, between the parties with respect thereto. 
 7. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO THE CONFLICTS OF LAW RULES OF SUCH STATE. 
 8. Each of
the parties hereby irrevocably and unconditionally consents to submit to the exclusive jurisdiction of the Delaware Court of Chancery in and for New Castle County, or in the event (but only in the event) that such court does not have subject matter
jurisdiction over such action or proceeding, the United States District Court for the District of Delaware, for any proceeding arising out of or relating to this Agreement and the Transactions (and agrees not to commence any proceeding relating
thereto except in such courts), and further agrees that service of any process, summons, notice or document by U.S. registered mail to its respective address set forth in this Agreement shall be effective service of process for any proceeding
brought against it in any such court. Each of the parties hereby irrevocably and unconditionally waives any objection to the laying of venue of any proceeding arising out of this Agreement or the Transactions in the Delaware Court of 

  

 2 

 
Chancery in and for New Castle County, or in the event (but only in the event) that such court does not have subject matter jurisdiction over such action or
proceeding, the United States District Court for the District of Delaware, and hereby further irrevocably and unconditionally waives and agrees not to plead or claim in any such court that any such proceeding brought in any such court has been
brought in an inconvenient forum. Each of the parties agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.

 9. EACH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION
DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 
 10. The provisions of this Termination Agreement may only be amended, modified or waived with the written consent of each party hereto. No failure or delay on the party of any party in exercising any right or remedy, or in requiring the
satisfaction of any condition, under this Termination Agreement shall operate as a waiver of, or impair, any such right, remedy or condition. No single or partial exercise of any such right, remedy or condition shall preclude any other or further
exercise thereof or the exercise of any other right, remedy or condition. No waiver of any right of a party under this Termination Agreement shall be effective unless given in writing by such party, or shall be deemed a waiver of any other right
hereunder. 
 11. None of the parties may assign any of its rights or delegate any of its obligations under this Termination
Agreement without the written consent of the other parties hereto, which consent shall not be unreasonably withheld. Any purported assignment or delegation absent such consent shall be null and void and without effect. This Termination Agreement
shall be binding upon, and shall inure to the benefit of, the successors to, or permitted assigns of, any of the parties. 
 12. The parties represent that they each have all right and authority necessary to grant the release and make the covenants set forth herein. 
 13. Each of the parties has jointly participated in the negotiation and drafting of this Termination Agreement. In the event of an ambiguity or a question of intent or interpretation arises, this Termination Agreement
shall be construed as if drafted jointly by each of the parties and no presumptions or burdens of proof shall arise favoring any party by virtue of the authorship of any of the provisions of this Agreement. 
 [Signatures on Next Page] 
  

 3 

 IN WITNESS WHEREOF, the parties have caused this Termination Agreement to be executed and delivered as of
the day and year first executed. 
  

			
	GMAC LLC
		
	By:	 	 /s/ Robert S. Hull

	Name:	 	Robert S. Hull
	Title:	 	Executive Vice President and Chief Financial Officer
	
	General Motors Corporation
		
	By:	 	 /s/ Ray G. Young

	Name:	 	Ray G. Young
	Title:	 	

  

			
	FIM Holdings, LLC
		
	By:	 	Cerberus FIM Investors, LLC, its Managing Member,
		
	By:	 	Cerberus FIM, LLC, its Managing Member,
		
	By:	 	 /s/ Stephen A. Feinberg

	Name:	 	Stephen A. Feinberg
	Title:	 	Managing Member

 [Signature Page to the Termination Agreement]Amendment No. 2, dated as of December 29, 2008, to Rights Agreement

 Exhibit 4.1 
 Execution Copy 
 AMENDMENT NO. 2 TO PEDIATRIX MEDICAL GROUP, INC. 
 PREFERRED SHARE PURCHASE RIGHTS PLAN 
 Amendment No. 2, dated as of December 29, 2008, to the Rights Agreement, dated as of March 31, 1999, as amended to the date hereof (the “Original Rights Agreement”), between Pediatrix Medical Group,
Inc., a Florida corporation (the “Company”), and Computershare Trust Company, N.A. (successor Rights Agent to BankBoston, N.A.), as rights agent (the “Rights Agent”). 
 W I T N E S S E T H 
 WHEREAS,
Section 26 of the Original Rights Agreement provides that at any time prior to person becoming an Acquiring Person (as such term is defined in the Original Rights Agreement) the Original Rights Agreement may be amended to effect any change
which the Company may deem necessary or desirable provided that such amendment is approved by a Majority Director Vote (as such term is defined in the Original Rights Agreement); and 
 WHEREAS, at least a majority in number of the total number of directors currently constituting the Company’s Board of Directors has voted to
approve the execution, delivery and performance of this Amendment by the Company, which vote constitutes a Majority Director Vote; and 
 WHEREAS, pursuant to the Agreement and Plan of Merger dated as of December 29, 2008, among the Company, Mednax, Inc. (“Holdings”) and PMG Merger Sub, Inc., the Company will reorganize its operations into a
holding company structure (the “Reorganization”), which will result in the Company becoming a direct, wholly owned subsidiary of Holdings; 
 WHEREAS, in connection with the Reorganization, the Company will transfer the Original Rights Agreement to Holdings by means of (i) this Amendment and (ii) the adoption of a substantially similar
rights agreement by Holdings; and 
 WHEREAS, the Company and the Rights Agent desire to amend the Original Rights Agreement as
provided in this Amendment, and upon execution of this Amendment by each of the parties hereto, the Original Rights Agreement will be so amended; 

 NOW, THEREFORE, the parties hereto agree as follows: 
 Section 1. Amendment to Definition of “Acquiring Person.” Section 1 of the Original Rights Agreement is hereby amended by
adding at the end of the definition of “Acquiring Person” the following: 
 Notwithstanding the foregoing, Mednax, Inc., a Florida
corporation, shall not be an Acquiring Person. 
 Section 2. Amendment to Definition of “Final Expiration Date.”
Section 7(a) of the Original Rights Agreement is hereby amended to read in its entirety as follows: 
 “(a) Subject to Sections
7(e), 11 and 13 and other provisions hereof, the registered holder of any Rights Certificate may exercise the Rights evidenced thereby (except as otherwise provided herein including, without limitation, the restrictions on exercisability set forth
in Section 9(c) and Section 23(a) hereof), in whole or in part, at any time after the Distribution Date, upon surrender of the Rights Certificate, with the form of election to purchase and the certificate on the reverse side thereof duly
executed, to the Rights Agent at the principal office of the Rights Agent designated for such purpose, together with payment of the aggregate Purchase Price for each one one-thousandth of a Preferred Share (or other securities) as to which the
Rights evidenced by such Rights Certificate are exercised, at or prior to the earliest of (i) the earlier of (x) the Effective Time (as defined in the Agreement and Plan of Merger dated as of December 29, 2008, among the Company,
Mednax, Inc., a Florida corporation and PMG Merger Sub, Inc., a Florida corporation, and (y) the close of business on March 31, 2009 (the earlier of (x) and (y) being referred to as the “Final Expiration Date”), the
time at which the Rights are redeemed as provided in Section 23 hereof (the “Redemption Date”), and (iii) the time at which the Rights are exchanged as provided in Section 11(r) hereof (the earliest of (i), (ii) and
(iii) being sometimes herein referred to as the “Expiration Date”).” 
 Section 3. Miscellaneous. The Company
shall notify the Rights Agent in the event that the Final Expiration Date is caused by the occurrence of the Effective Time. Except as expressly amended by this Amendment, the Original Rights Agreement shall remain in full force and effect in
accordance with its terms. Sections 27, 28, 30, 31, 32, 33 and 34 of the Original Rights Agreement shall apply to this Amendment mutatis mutandis. This Amendment may be executed in any number of counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. 
 [Remainder of page intentionally left blank] 
  

 2 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their
respective authorized officers as of the day and year first above written. 
  

					
	PEDIATRIX MEDICAL GROUP, INC.
		
	 By:
	 	 /s/ Karl B. Wagner

		 	Name:  	 	Karl B. Wagner
		 	Title:	 	Chief Financial Officer

  

					
	COMPUTERSHARE TRUST COMPANY, N.A.
		
	 By:
	 	 /s/ Katherine S. Anderson

		 	Name:  	 	Katherine S. Anderson
		 	Title:	 	Managing Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00151-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00151-of-00352.parquet"}]]